Unicycive Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Unicycive Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2022 to Q3 2024.
  • Unicycive Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -61.4 %, a 60.4% increase year-over-year.
  • Unicycive Therapeutics, Inc. annual Return On Assets for 2023 was -146 %, a 16% increase from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -61.4 +93.8 +60.4% Jul 1, 2024 Sep 30, 2024
Q2 2024 -71.1 +115 +61.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -136 +83.9 +38.2% Jan 1, 2024 Mar 31, 2024
Q4 2023 -146 +27.8 +16% Oct 1, 2023 Dec 31, 2023
Q3 2023 -155 -47.5 -44.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -186 -95.6 -106% Apr 1, 2023 Jun 30, 2023
Q1 2023 -220 -128 -141% Jan 1, 2023 Mar 31, 2023
Q4 2022 -174 Oct 1, 2022 Dec 31, 2022
Q3 2022 -108 Jul 1, 2022 Sep 30, 2022
Q2 2022 -90.2 Apr 1, 2022 Jun 30, 2022
Q1 2022 -91.2 Jan 1, 2022 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.